Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France.
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France.
Euro Surveill. 2021 Jan;26(1):
Authors: Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S
Abstract
We used a mathematical model to evaluate the impact of mass testing in the control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Under optimistic assumptions, one round of mass testing may reduce daily infections by up to 20-30%. Consequently, very frequent testing would be required to control a quickly growing epidemic if other control measures were to be relaxed. Mass testing is most relevant when epidemic growth remains limited through a combination of interventions.
PMID: 33413741 [PubMed - in process]
Source: Euro Surveill - Category: Infectious Diseases Authors: Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S Tags: Euro Surveill Source Type: research
More News: Coronavirus | COVID-19 | Epidemics | Epidemiology | France Health | Infectious Diseases | Respiratory Medicine | SARS | Study